Solobacterium moorei: Difference between revisions

From IDWiki
Solobacterium moorei
Content deleted Content added
Created page with "== Background == * Non-spore-forming strictly anaerobic Stain::Gram-positive Shape::bacillus * Typically isolated from human feces and difficult to cluster == Clinical Manifestations == * Associated with halitosis and odontogenic infections * Rare bacteremia, particularly in immunocompromised peopleCiteRef::detry2006seCiteRef::pedersen2011so * Rare wound infections == Management == * Appears to be generally susceptible to most antibiotics, including..."
 
No edit summary
 
Line 1: Line 1:
{{DISPLAYTITLE:''Solobacterium moorei''}}

== Background ==
== Background ==


Line 13: Line 15:


* Appears to be generally susceptible to most antibiotics, including penicillin, piperacillin-tazobactam, clindamycin, metronidazole, meropenem, moxifloxacin, tigecycline, and vancomycin[[CiteRef::detry2006se]][[CiteRef::zheng2010ph]][[CiteRef::pedersen2011so]]
* Appears to be generally susceptible to most antibiotics, including penicillin, piperacillin-tazobactam, clindamycin, metronidazole, meropenem, moxifloxacin, tigecycline, and vancomycin[[CiteRef::detry2006se]][[CiteRef::zheng2010ph]][[CiteRef::pedersen2011so]]
[[Category:Gram-positive bacilli]]
[[Category:Anaerobes]]

Latest revision as of 15:59, 3 October 2025


Background

  • Non-spore-forming strictly anaerobic Gram-positive bacillus
  • Typically isolated from human feces and difficult to cluster

Clinical Manifestations

  • Associated with halitosis and odontogenic infections
  • Rare bacteremia, particularly in immunocompromised people12
  • Rare wound infections

Management

  • Appears to be generally susceptible to most antibiotics, including penicillin, piperacillin-tazobactam, clindamycin, metronidazole, meropenem, moxifloxacin, tigecycline, and vancomycin132

References

  1. a b  G. Detry, D. Pierard, K. Vandoorslaer, G. Wauters, V. Avesani, Y. Glupczynski. Septicemia due to Solobacterium moorei in a patient with multiple myeloma. Anaerobe. 2006;12(3):160-162. doi:10.1016/j.anaerobe.2006.04.002.
  2. a b  Rune Micha Pedersen, Hanne Marie Holt, Ulrik Stenz Justesen. Solobacterium moorei Bacteremia: Identification, Antimicrobial Susceptibility, and Clinical Characteristics. Journal of Clinical Microbiology. 2011;49(7):2766-2768. doi:10.1128/jcm.02525-10.
  3. ^  

    Guili Zheng, Paula H. Summanen, David Talan, Robert Bennion, Marie-Claire Rowlinson, Sydney M. Finegold. Phenotypic and Molecular Characterization of

               Solobacterium moorei
               Isolates from Patients with Wound Infection. Journal of Clinical Microbiology. 2010;48(3):873-876. doi:10.1128/jcm.01381-09.